Publications - Matthew J. Ferber, Ph.D.

Back to research profile

1. Lindor NM, Johnson KJ, McCormick JB, Klee EW, Ferber MJ, Farrugia G. Preserving personal autonomy in a genomic testing era. Genet Med. 2013 May; 15(5):408-9.
   View PubMed
2. Kerr SE, Thomas CB, Thibodeau SN, Ferber MJ, Halling KC. APC germline mutations in individuals being evaluated for familial adenomatous polyposis: a review of the Mayo Clinic experience with 1591 consecutive tests. J Mol Diagn. 2013 Jan; 15(1):31-43. Epub 2012 Nov 14.
   View PubMed
3. Klee EW, Hoppman-Chaney NL, Ferber MJ. Expanding DNA diagnostic panel testing: is more better? Expert Rev Mol Diagn. 2011 Sep; 11(7):703-9.
   View PubMed
4. Hoppman-Chaney N, Peterson LM, Klee EW, Middha S, Courteau LK, Ferber MJ. Evaluation of oligonucleotide sequence capture arrays and comparison of next-generation sequencing platforms for use in molecular diagnostics. Clin Chem. 2010 Aug; 56(8):1297-306. Epub 2010 Jun 18.
   View PubMed
5. Kegley KM, Sellers MA, Ferber MJ, Johnson MW, Joelson DW, Shrestha R. Fulminant Wilson's disease requiring liver transplantation in one monozygotic twin despite identical genetic mutation. Am J Transplant. 2010 May; 10(5):1325-9. Epub 2010 Mar 19.
   View PubMed
6. Mensink K, Ferber M. Genetic tests physicians should know. Minn Med. 2007 May; 90(5):33-5.
   View PubMed
7. Kitzmann AS, Pulido JS, Ferber MJ, Highsmith WE, Babovic-Vuksanovic D. A splice-site mutation in CCM1/KRIT1 is associated with retinal and cerebral cavernous hemangioma. Ophthalmic Genet. 2006 Dec; 27(4):157-9.
   View PubMed
8. Kroll CA, Ferber MJ, Dawson BD, Jacobson RM, Mensink KA, Lorey F, Sherwin J, Cunningham G, Rinaldo P, Matern D, Hahn SH. Retrospective determination of ceruloplasmin in newborn screening blood spots of patients with Wilson disease. Mol Genet Metab. 2006 Sep-Oct; 89(1-2):134-8. Epub 2006 Apr 27.
   View PubMed
9. Baudhuin LM, Ferber MJ, Winters JL, Steenblock KJ, Swanson RL, French AJ, Butz ML, Thibodeau SN. Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients. Gastroenterology. 2005 Sep; 129(3):846-54.
   View PubMed
10. Yu TX, Ferber MJ, Cheung TH, Chung TKH, Wong YF, Smith DI. The role of viral integration in the development of cervical cancer. Cancer Genetics & Cytogenetics. 2005 Apr 1; 158(1):27-34.
11. Ferber MJ, Eilers P, Schuuring E, Fenton JA, Fleuren GJ, Kenter G, Szuhai K, Smith DI, Raap AK, Brink AA. Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13. Cancer Genet Cytogenet. 2004 Oct 1; 154(1):1-9.
    View PubMed
12. Ferber MJ, Thorland EC, Brink AA, Rapp AK, Phillips LA, McGovern R, Gostout BS, Cheung TH, Chung TK, Fu WY, Smith DI. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene. 2003 Oct 16; 22(46):7233-42.
    View PubMed
13. Ferber MJ, Montoya DP, Yu C, Aderca I, McGee A, Thorland EC, Nagorney DM, Gostout BS, Burgart LJ, Boix L, Bruix J, McMahon BJ, Cheung TH, Chung TK, Wong YF, Smith DI, Roberts LR. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene. 2003 Jun 12; 22(24):3813-20.
    View PubMed
14. Denison SR, Becker NA, Ferber MJ, Phillips LA, Kalli KR, Lee J, Lillie J, Smith DI, Shridhar V. Transcriptional profiling reveals that several common fragile-site genes are downregulated in ovarian cancer. Genes Chromosomes Cancer. 2002 Aug; 34(4):406-15.
    View PubMed
15. Ferber MJ, Maher LJ 3rd. Combinatorial selection of a small RNA that induces amplification of IncFII plasmids in Escherichia coli. J Mol Biol. 1998 Jun 12; 279(3):565-76.
    View PubMed
16. Ferber MJ, Maher LJ 3rd. Quantitating oligonucleotide affinities for duplex DNA: footprinting vs electrophoretic mobility shift assays. Anal Biochem. 1997 Jan 15; 244(2):312-20.
    View PubMed